The Epoch Times President Joe Biden Tuesday directed the federal government to double its purchase of Pfizer’s oral antiviral treatment, Paxlovid. This addition increases the U.S. total purchase from Pfizer from 10 million to 20 million therapeutic courses of the new pill.
The U.S. Food and Drug Administration (FDA) authorized the emergency use of Paxlovid last month for the treatment of COVID-19 in patients over the age of 12.
“These pills are going to dramatically decrease hospitalizations and deaths from COVID-19,” said Biden in a speech Jan. 4. “They’re a game changer and have the potential to dramatically alter the impact of COVID-19.”…
